Monitoring and Antibiotic Resistance Profile of Tracheal Aspirate Microbiota in ICU Children with Severe Craniocerebral Trauma

Nosocomial infections and their rational antibiotic treatment represent a major challenge for the healthcare nowadays. In this context, gramnegative bacteria including Pseudomonas aeruginosa, Acinetobacter baumanii and Enterobacteriaceae spp. are etiologically important and characterized by a significant level of antibiotic resistance. To examine dynamics of the respiratory tract colonization by hospital flora, tracheal aspirates obtained at three time points from 69 children with severe craniocerebral trauma during their stay in ICU were analysed. Colonization was observed on the 4^th day of the ICU stay with predomination of K.pneumoniae (45%) and A.baumanii (27-37%). P.aeruginosa was detected after the 8^th day of the ICU stay with the isolation rate of 33%. Substantial proportions of P.aeruginosa (61%), A.baumanii (78%) and K.pneumoniae (25%) were resistant to carbapenems. In 65 carbapemen resistant isolates, the presence of carbapenemases was examined using PCRs. OXA-48 carbapenemase was detected in 11 out of 14 (78%) K.pneumoniae isolates. Among the A.baumanii isolates, 30/31 (97%) carried OXA-40 and 1/31 (3%) had OXA-23 carbapenemases. None of the examined A.baumanii and K.pneumoniae isolates produced metallo-betalactamases (MBL). In contrast, all 20 car-bapenem resistant P.aeruginosa isolates produced a MBL, and in 12 out of 20 (60%) of theme VIM-2 was detected. Thus, gramnegative nosocomial microflora rapidly colonizes ICU patients and has a high level of resistance to antibiotics, including carbapenems.

nosocomial microbiota, intensive care unit, antibiotic resistance, carbapenemases, children

1. Шагинян И.А., Чернуха М.Ю. Неферментирующие грамотрицательные бактерии в этиологии внутрибольничных инфекций: клинические, микробиологические и эпидемиологические особенности. Клин микробиол антимикроб химиотер 2005; 7: 3: 271-285.

2. Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H., Wolff M., Spencer R.C., Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639-644.

3. Weber D.J., Raasch R., Rutala W.A. Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens. Chest 1999; 115: 34-41.

4. Alberti C., Brun-Buisson C., Burchardi H., Martin C., Goodman S., Artigas A., Sicignano A., Palazzo M., Moreno R., Boulmé R., Lepage E., Le Gall R. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28: 108-121.

5. Козлов Р.С., Стецюк О.У., Андреева И.В. Современные тенденции антибиотикорезистентности возбудителей нозокомиальных инфекций в ОРИТ России: что нас ждет дальше? Интенсив тер 2007; 4: 4.

6. Hartmann B., Junger A., Brammen D., Röhrig R., Klasen J., Quinzio L., Benson M., Hempelmann G. Antibiotic usage in an intensive care unit in a Danish university hospital. J Antimicrob Chemother 1993; 32: 633-642.

7. Plowman R., Graves N., Griffin M.A., Roberts J.A., Swan A.V., Cookson B., Taylor L. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialists of a district general hospital in England and the national burden imposed. J Hospital Infection 2001; 47: 198-209.

8. Richards M.J., Edwards J.R., Culver D.H., Gaynes R.P. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27: 5: 887-892.

9. Geffers C., Zuschneid I., Sohr D., et al. Microbiological isolates associated with nosocomial infections in intensive care units: data of 274 intensive care units participating in the German Nosocomial Infections Surveillance System (KISS). Anesthesiol Intensivmed Notfallmed Schmerzther 2004; 39: 1: 15-19.

10. Pfaller M.A., Jones R.N., Doern G.V. et al. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42: 7: 1762-1770.

11. Schwaber M.J., Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 60: 913-920.

12. Семина Н.А., Страчунский Л.С., Козлов Р.С. и др. Состояние антибиотикорезистентности грамотрицательных возбудителей нозокомиальных инфекций в отделениях интенсивной терапии. Информационное письмо. Available from: www.antibiotic.ru/iac-mac/ru/pub/letters/argrmnoz/.

13. Решедько Г.К., Рябкова Е.Л., Кречикова О.И., Сухорукова М.В., Шевченко О.В., Эйдельштейн М.В., Козлов Р.С., исследовательская группа РОСНЕТ. Антибиотикорезистентность грамотрицательных возбудителей нозокомиальных инфекций в отделениях реанимации и интенсивной терапии России. Клин микробиол антимикроб химиотер 2008; 10: 2: 163-179.

14. Галкин Д.В. Карбапенемы через 20 лет после открытия: современные микробиологические и клинические аспектыю Клин микробиол антимикроб химиотер 2007; 9: 2: 133-152.

15. Bush K., Jacoby G.A., Medeiros A. A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211-1233.

16. Queenan A.M., Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007; 20: 440-458.

17. Walsh T.R. Clinically significant carbapenemases: an update. Curr Op Infect Dis 2008; 21: 367-371.

18. Pournaras S., Protonotariou E., Voulgari E., Kristo I., Dimitroulia E., Vitti D., Tsalidou M., Maniatis A.N., Tsakris A., Sofianou D. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother 2009; 64: 348-352.

19. Woodford N., Zhang J., Warner M. et al. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother 2008; 62: 1261-1264.

20. Gupta V. Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species. Expert Op Invest Drugs 2008; 17: 131-143.

21. Тапальский Д.В., Осипов В.А., Жаворонок С.В. Карбапенемазы грамотрицательных бактерий: распространение и методы детекции. Мед журн 2012; 2: 10-15.

22. Плохинский Н.А. Биометрия. М.: 1970; 367

23. Мартинович А.А. Динамика антибиотикорезистентности и эпидемиология инфекций, вызванных A.baumannii, в России. Клин микробиол антимикроб химиотер 2010; 12: 2: 94-105.

24. Woodford N., Turton J.F., Livermore D.M. Multiresistant gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev. 2011; 35: 5: 736-755.

25. Castanheira M., Deshpande L.A., Costello A., Davies T.A., Jones R.N. Epidemiology of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries. J Antimicrob Chemother 2014 March.

26. Cuzon G., Ouanich J., Gondret R., Naas T., Nordmannl P. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother 2011; 5: 2420-2423.